Feed aggregator
New marine scale worm species first to provide evidence of male dwarfism
Researchers recently found a new species of scale worms (Annelida: Polynoidae) living mostly in pairs with a striking difference compared to the almost 900 already known species of scale worms: one was a quarter the size of its mate.
Categories: Content
Mothers transmitting hepatitis B to children as broken hospital procedures plague Europe
Procedures to prevent the direct transmission of hepatitis B virus (HBV) from mother to child, particularly during and after pregnancy, have significant fragmentation and gaps, a new survey presented at the 6th World Congress of Paediatric Gastroenterology, Hepatology and Nutrition has shown.
Categories: Content
Screening reveals coeliac disease cases in children have doubled in 25 years
(Geneva, 5 June 2021) Mass screening of school-age children has led to significantly higher numbers of coeliac disease cases being diagnosed, according to a new study presented today at the 6th World Congress of Paediatric Gastroenterology, Hepatology and Nutrition.
Categories: Content
SLAS Technology June special issue on 3D cell culture
The June edition of SLAS Technology is a Special Issue entitled, 'Emerging Trends in 3D Cell Culture: High-Throughput Screening, Disease Modeling and Translational Medicine.' Free online access to the articles in this collection is courtesy of Corning Life Sciences, the issue's sponsor.
Categories: Content
Nutritional supplement proves 92% effective in boosting brain function
Individuals with communication disorders report improvement with focus, speech, and motor skills, after using a patented nutritional supplement.
Categories: Content
SLAS Discovery's June issue on synthetic biology available now
The June edition of SLAS Discovery features the cover article, 'A Perspective on Synthetic Biology in Drug Discovery and Development -- Current Impact and Future Opportunities' by Florian David, Ph.D. (Chalmers University of Technology, Gothenburg, Sweden), Andrew M. Davis, Ph.D. (AstraZeneca, Cambridge, England, UK). Michael Gossing, Ph.D., Martin A. Hayes, Ph.D., and Elvira Romero, Ph.D., and Louis H. Scott, Ph.D. (AstraZeneca, Gothenburg, Sweden), and Mark J. Wigglesworth, Ph.D. (AstraZeneca, London, England, UK).
Categories: Content
Study finds lower mortality rate for men at high risk for death from prostate cancer who received early postoperative radiation therapy
A new, retrospective study focuses on men who have both high-grade prostate cancer that extends outside the prostate and/or has spread into the lymph nodes. For these men who are at high risk of dying from the disease, there was a significant reduction in the risk of death with adjuvant radiation therapy (aRT) use, suggesting that it should be offered to these men.
Categories: Content
Computer simulations of the brain can predict language recovery in stroke survivors
Speech rehabilitation experts can predict how well a patient will recover from aphasia, a disorder caused by damage to the part of the brain responsible for producing language.
Categories: Content
Colorectal Cancer: UVA Health Expert Helps Develop New National Screening Guidelines
Most Americans should get screened for colorectal cancer beginning at age 45 instead of age 50, according to new recommendations from the U.S. Preventive Services Task Force, which includes UVA Health's Li Li, MD, PhD, MPH. This recommendation applies to Americans without symptoms who do not have a history of colorectal polyps or a personal or family health history of genetic disorders that increase the risk of colorectal cancer.
Categories: Content
Social identity within the anti-vaccine movement
A study of more than 1,000 demographically representative participants found that about 22 percent of Americans self-identify as anti-vaxxers, and tend to embrace the label as a form of social identity.
Categories: Content
New form of silicon could enable next-gen electronic and energy devices
A team led by Carnegie's Thomas Shiell and Timothy Strobel developed a new method for synthesizing a novel crystalline form of silicon with a hexagonal structure that could potentially be used to create next-generation electronic and energy devices with enhanced properties that exceed those of the "normal" cubic form of silicon used today.
Categories: Content
New drug effective against lung cancers caused by common genetic error
A new drug reduced tumor size in patients who have lung cancer patients with a specific, disease-causing change in the gene KRAS, a study found.
Categories: Content
Beyond synthetic biology, synthetic ecology boosts health by engineering the environment
In a new Nature Communications study, researchers from BU's Microbiome Initiative discovered that providing microbial communities with a broader variety of food sources didn't increase the variety of microbial species within their experiments, but more food did fuel more microbial growth. The team's ultimate goal is to learn how to direct microbiome behavior through environmental molecules like food sources.
Categories: Content
Magnetism drives metals to insulators in new experiment
A new experiment offers the cleanest proof yet for magnetism-driven transitions of metals to insulators.
Categories: Content
Why scientists want to solve an underground mystery about where microbes live
A team of BU biologists revealed, for the first time, that it is possible to accurately predict the abundance of different species of soil microbes in different parts of the world.
Categories: Content
Fungus creates a fast track for carbon
New research focused on interactions among microbes in water suggests fungal microparasites play a bigger than expected role in aquatic food webs and the global carbon cycle.
Categories: Content
"Mexican variant" and monitoring actions of SARS-CoV-2 genome
It has recently become prominent in Mexico and, similarly to other variants, presents a mutation in the Spike protein of the coronavirus. The "Mexican variant" was identified by a research group of the University of Bologna
Categories: Content
Newly approved targeted therapy sotorasib prolongs survival in KRAS G12C-mutated lung cancer
Results from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib achieved a 37.1% objective response rate and 12.5 months median overall survival in previously treated patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.
Categories: Content
Substantial carbon dioxide emissions from northern peatlands drained for crop cultivation
A new study shows that substantial amounts of carbon dioxide were released during the last millennium because of crop cultivation on peatlands in the Northern Hemisphere.
Categories: Content
Soft tissue measurements critical to hominid reconstruction
Accurate soft tissue measurements are critical when making reconstructions of human ancestors, a new study from the University of Adelaide and Arizona State University has found.
Categories: Content